Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04669067
Title TL-895 and KRT-232 Study in Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Telios Pharma, Inc.
Indications

acute myeloid leukemia

Therapies

KRT-232 + TL-895

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | AUT

Additional content available in CKB BOOST